Latest ArticlesDue to the lack of methods for investigating gel-forming behaviors, hydrophilic matrix tablets always face unnecessary risks in in vivo evaluation. In recent years, with the development of in vitro simulated detection methods, studies have been conducted to quantify the strength and robustness of the gel layer of hydrophilic matrix tablets by puncturing, rheological testing, mass and volume measurement, and transmission imaging. These gel strength detection methods are continuously developed and applied in early research and development. In this review, in vitro-in vivo correlation of hydrophilic matrix tablets, gel strength detection methods, and critical influences of formulation and process parameters, are summarized to provide a brief reference for the relevant studies and manufacturing on gel matrix tablets.
In this paper, using Rink Amide MBHA resin as the carrier, Fmoc-protected amino acids as the raw materials, 1-hydroxybenzotriazole(HOBt)/N, N'-diisopropylcarbodiimide(DIC) as the condensation reagents, and trifluoroacetic acid(TFA) system as the lysis solution, the prototype setmelanotide(1) crude peptide was synthesized by a solid-phase synthesis method according to the amino acid sequence of 1, a weight loss agent. Then the oxidative type 1 was obtained by hydrogen peroxide oxidation method. After separation and purification by the RP-HPLC method, the 1 purified product with a purity of more than 98% was obtained. The total yield of this process was about 47%. The related process parameters in the preparation process of 1 were discussed and optimized. In line with the principle of improving yield and reducing cost, the process parameters of each link were clarified and kept within a controllable range, which laid the foundation for its industrialized large-scale production and also provided a technical reference for other peptide drug researches.
To improve quality control of remdesivir, the key chiral impurities easily generated in the production process of remdesivir were designed and synthesized. The structures of these compounds included (S)-2-ethylbutyl 2-[[(S)-[[(2R,3S,4R,5S)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]-methoxy](phenoxy)phosphoryl]amino]propanoate, (S)-2-[(R)-(2R,3S,4R,5R)]-type and (S)-2-[(R)-(2R,3S,4R,5S)]-type optical isomers were confirmed by MS and NMR. This method was suitable for laboratory synthesis due to its mild reaction conditions, high yield and no need for chiral separation.
This paper reported the fermentation expression, separation and purification, activity assay, and enzymatic property analysis of pig-baboon chimeric urate oxidase(1). Recombinant Escherichia coli high-density fermentation technique was used to express 1 in inclusion body form, and the fermentation yield was 6.88 g/L. The inclusion bodies were extracted by alkali solution and purified by anion-exchange chromatography to obtain the target protein with a purity of 99.61%, and the total enzyme activity yield was 78.95%. According to the results of mass spectrometric identification and enzyme activity analysis, the relative molecular weight of a single subunit was correct, and the specific activity reached 6.25 u/mg, which proved that 1 was correctly expressed in E. coli and capable of degrading uric acid. This study provided a methodological reference for efficiently preparing 1 drugs.
The composites of berberine hydrochloride(BH) and four kinds of bile salts, namely sodium cholate, sodium taurocholate, sodium deoxycholate and sodium taurodeoxycholate(STD), with different molar ratios were respectively prepared. The composite of BH and STD with molar ratio of 1∶1 was screened out according to the results of complexing rate. Then, the dropping pills based on above composite were prepared to improve the oral bioavailability of berberine. The matrix and the ratio of matrix to composite were optimized with the hardness, roundness, weight variation and dissolution in vitro as the indicators. The results showed that the optimal dropping pills with the matrix composed of polyethylene glycol(PEG) 6000 and PEG 400 at a weight ratio of 4∶2 were obtained when mass ratio of the matrix to the composite was 9∶1. The results of differential scanning calorimetry and Fourier transform infrared spectroscopy showed the formations of the composite BH-STD and the pills BH-STD-DP. The dissolution at 20 min of three batches of BH-STD-DP were all above 90%. The suspension of BH and BH-STD-DP were administered intragastrically to the rats, and the results showed that the relative oral bioavailability of BH-STD-DP group was 208.41%, indicating this product could significantly improve the oral bioavailability of berberine.
To prolong action time and reduce administration frequency, helicid sustained-release tablets were prepared by wet granulation with hypromellose and carbomer as the matrix materials. And the in vitro release and pharmacokinetics in Beagle dogs were investigated. The results of in vitro release test showed that the cumulative release at 10 h in deionized water reached 98.3%, and Higuchi equation fit the release data of helicid well(r=0.998 2). The pharmacokinetics was carried out in Beagle dogs. The parameters AUC0→∞, cmax, t1/2 for the sustained-release tablets and the common tablets were as follows: (1.665±0.264) and (1.552±0.076)μg·ml–1·h, (0.46±0.05) and (1.24±0.12)μg/ml,(5.29±2.30) and (0.57±0.12)h, respectively. The above results showed that helicid sustained-release tablets had an obvious sustained-release characteristics and reduced the fluctuation of blood drug concentration.
A definitive screening design(DSD, software JMP 13.0 Pro) was undertaken to preliminarily screen the formulation and process parameters of spray-dried powders of oxytocin for inhalation. Six formulation and process parameters, namely phosphate radio, leucine radio, pH of feed solution, inlet temperature, feed solution flow rate and airflow rate, were set as the influence factors, then 13 batches of oxytocin powder were prepared and characterized in terms of fine particle fraction, yield, glass transition temperature, moisture content, geometric median diameter, oxytocin content. The results showed that fine particle fraction was mainly influenced by phosphate radio and leucine radio, whereas yield was found to be primarily affected by leucine radio, and moisture content was mainly influenced by phosphate radio and feed solution flow rate. Finally, the optimal formulation and process parameters of spray-dried powders of oxytocin was obtained with fine particle fraction and oxytocin content as key indicators through joint modeling. The results of verification test showed that the optimized powders were basically in line with the requirements of oxytocin dry powder for inhalation, with fine particle fraction of 89.14%, moisture content of 0.67%, oxytocin content of 94.63%, geometric median diameter of 1.36 μm and yield of 68.50%. In conclusion, DSD can quickly screen and quantify the influence of the formulation or process parameters on powder properties in the early development of peptide dry powder inhalation.
To establish the 2nd WHO international standard for recombinant human insulin-like growth factor-Ⅰ(IGF-Ⅰ), an international collaborative standardization was organized by National Institute for Biological Standards and Control(NIBSC). The study was conducted in two phases. Our institute(National Institutes for Food and Drug Control) took part in phase 1. Taking primary calibrant PS01 as reference standard, the content of candidate international standard(IS) was determined by HPLC, using standard curve method. The results of system suitability test met requirements in the protocol, and the data of 3 assays(32.874, 33.099 and 33.042 μg per ampoule, respectively) submitted by our laboratory had been all adopted. The mean value was 33.005 μg per ampoule, which was basically consistent with the assigned content (33.0 μg per ampoule) of the candidate IS(19/166). At present, the candidate IS(19/166) has been used as the 2nd WHO international standard for IGF-Ⅰ on NIBSC website. This research provided a reference for the establishment and standardization of national reference substance in China.
In the pharmaceutical preparations of secondary amine drugs, such as bisoprolol, reported in literature, if lactose monohydrate(3) was used as an adjuvant, the drug might react with 3, resulting in the N-formylation product as the final and maximum impurity. According to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use(ICH) Q1 guideline, the HPLC method was used to determine the metoprolol tartrate(1) tablets stored under the accelerated condition(40 ℃, relative humidity of 75%) for six months, and one largest impurity was found with a content of more than 0.2%. According to the results of synthesis, separation and identification tests, it was proved to be maltol(4), which was different from those in existing literature. In addition, the Maillard reaction products of several different amines with 3 were detected, including propranolol, which had a very similar structure of metoprolol(2), but none of them was 4. The bacterial mutagenic effects of 4 was reported, but currently the regulatory agencies considered 4 to be safe, which might be the reason why 3 was used as an excipient in 1 tablets currently on the market. However, from the perspective of absolute safety, it is recommended to avoid the combination of amine compounds with 3 and other reducing sugars.
An HPLC method was established for the determination of related substances, namely 2'-chloroacetophenone(2), 2-bromo-2'-chloroacetophenone(3), 2,2-bromo-2'-chloroacetophenone(4),1-(2-chlorophenyl) ethanol(5), 2-chlorophenyl ethylene oxide(6), 1-(2-chlorophenyl)-1,2-glycol(7), 2,2-bromo-2'-chlorophenethyl alcohol(8) and 1-tert-butylamino-1-(2-chlorophenyl)ethanol hydrochloride(9), in tulobuterol hydrochloride(1). The Agilent Zorbax Eclipse Plus C18 column(4.6 mm×250 mm, 5 µm) was used, and the analysis was carried out in the gradient elution mode, with sodium octane sulfonate buffer∶acetonitrile(90∶10) as mobile phase A, and acetonitrile as mobile phase B. The flow rate was 1.0 ml/min, the detection wavelength was 215 nm, and the column temperature was 30 ℃. The results showed that the peaks of 1 and impurities 2 - 9 were well separated, and it was linear for 1 - 9 in the corresponding concentration ranges. The average recoveries(n=12) of 2 - 9 were 100.3% - 106.6%, with the RSDs of 2.6% - 8.7%. The detection limit was 0.05 µg/ml for 1, 2, 3, 5, 6, 7 and 9, and 0.15 µg/ml for 4 and 8. The established method has good accuracy and high sensitivity, which can be used for the determination of related substances in 1.